Medicine and Dentistry
Vulvodynia
67%
Mediator
51%
Emergency Department
41%
Cervical Cancer Screening
41%
Inflammatory Mediator
28%
Fibroblast
25%
Chronic Pain
23%
Gabapentin
20%
Toll Like Receptor
20%
Dysmenorrhea
20%
Uterine Cervix Dysplasia
20%
Nevus Sebaceous
20%
Placebo
20%
Transient Receptor Potential Channel
20%
TRPV4
20%
Coherence
20%
Vestibule of the Ear
19%
Disease
17%
Intraepithelial Neoplasia
16%
Histopathology
12%
Wart Virus
9%
Prostaglandin E2
9%
K-Complex
8%
Imiquimod
7%
Toll Like Receptor 7
7%
Skin Flap
6%
Myalgia
5%
Pelvis
5%
Innate Immunity
5%
Calcium Transport
5%
Lipidomics
5%
Phorbol Didecanoate
5%
Vulva
5%
Cancer Screening
5%
Immunity
5%
Keyphrases
Vulvodynia
41%
Localized Provoked Vulvodynia
37%
Chronic Pain
24%
Inflammatory Mediators
24%
Novel Mechanism
20%
Inflammatory Mediator Production
20%
C.albicans
20%
Clinical Treatment
20%
Dysmenorrhea
20%
Community-dwelling Women
20%
Verrucous Epidermal Nevus
20%
Transient Receptor Potential Cation Channel Subfamily V Member 4
20%
Gabor-domain Optical Coherence Microscopy
20%
Pain Development
20%
Prostaglandin E2
19%
Fibroblasts
19%
Interleukin-6
19%
Inflammatory Response
17%
Vulvar
15%
Inflammation
13%
Dectin-1
12%
Proinflammatory Stimuli
8%
Nuclear factor-κB
8%
Resource-based Approach
8%
Squamous Intraepithelial Neoplasia
8%
Disabling Conditions
6%
Vestibule
6%
Chronic Conditions
6%
Pro-resolving
6%
Patient Experience
6%
Multifactorial Disorder
6%
Women's Health Issues
6%
Diminished Quality of Life
6%
Treatment Advances
6%
TRPV4 Antagonist
6%
HC067047
6%
Therapeutic Target
6%
Surface Electromyographic Biofeedback
5%
Peripheral Sensitization
5%
Linear Epidermal Nevus
5%
Immunology and Microbiology
Mediator
100%
Fibroblast
67%
Inflammation Response
22%
Receptor Potential
20%
Candida Albicans
20%
Toll-Like Receptor
20%
Prostaglandin E2
19%
Interleukin 6
14%
Women's Health
10%
Interleukin-6
10%
Dectin 1
10%
Immunity
6%
Agonist
6%
Calcium Transport
6%
Nuclear Factor Kappa B
6%
Vulva
6%
Imiquimod
5%
